For reference on class-related adverse effects and warnings, the Summary of Product Characteristics (SmPC) for approved GLP-1 and dual GIP/GLP-1 receptor agonists including Wegovy (semaglutide) and Mounjaro (tirzepatide) are available on the Electronic Medicines Compendium (www.medicines.org.uk/emc)
Can we reap its slimming benefits without pricey injections
The sooner that is clarified, the sooner you can stop guessing and start treating the actual cause
Semaglutide offers a viable option for individuals seeking medical assistance in their weight loss journey
Where on the body should I inject
Footnotes CONFLICTS OF INTEREST In the last 5 years Adie Viljoen has received lecture honoraria and/or travel support and/or conducts clinical trials funded by: Amarin, Amgen, Astra Zeneca, Boehringer Ingleheim, Daiichi-Sankyo, Lilly, Menarini, NewAmsterdam, Novartis, Novo Nordisk, Pfizer, Regeneron, Sanofi, Takeda, and Tosoh